U.S. Healthtech Stock News

With inflation running at 4.2%, a hawkish Fed chair talking about higher rates, and energy costs pushed up by geopolitical conflict, value stocks are back under the spotlight. Higher borrowing costs and pricing pressure can reshuffle which companies look attractively priced and which look stretched. This article focuses on a U.S. Value Stocks screener that filters for relatively low P/E and P/B ratios in larger, established businesses. It will walk through 3 stocks that appear positively...

Quantum computing stocks sit at the intersection of cutting-edge research and real-world problem solving, and that mix is attracting attention while traditional surveys and PMIs signal patchy growth, shifting rate expectations, and uneven demand across regions. The Quantum Computing Stocks screener filters this complex space for you by surfacing companies working on quantum algorithms, superconducting qubits, and related software tools. Instead of trying to track every macro headline, you can...

If you are wondering whether IQVIA Holdings is attractively priced or looking stretched, this article breaks down what the current share price might imply about value. The stock last closed at US$171.28, with the share price up 2.0% over the past month but down 24.0% year to date and 29.8% over five years. The 1 year return stands at 8.0% and the 3 year return shows a 20.2% decline. Recent coverage around IQVIA Holdings has focused on its role in life sciences data and clinical services, as...

If you are wondering whether Sensient Technologies stock still offers value at current levels, this article focuses squarely on what the numbers say about its price. Over recent periods, the stock has recorded returns of 6.3% over 7 days, 3.8% over 30 days, 27.1% year to date, 23.3% over 1 year, 80.8% over 3 years, and 52.4% over 5 years. This naturally raises questions about how its current valuation stacks up. Recent coverage around Sensient Technologies has focused on its role in the...

Bitmine Immersion Technologies (NYSE:BMNR) is approaching inclusion in the Russell 1000 index, which would trigger buying by index-tracking funds once finalized. The company has co founded Ethlabs, a new nonprofit research lab focused on Ethereum, with the goal of supporting institutional use of the network. Bitmine Immersion Technologies operates in the crypto infrastructure space, where institutional interest in digital assets and blockchain tooling continues to evolve. Potential...

With the US Federal Reserve under Kevin Warsh signaling a more hawkish stance and bond yields reacting, short term US Treasury and government bond ETFs are back in focus for investors weighing risk and income. As markets adjust to the prospect of rate hikes and a smaller, less interventionist central bank, some stocks exposed to this news may appear better positioned than others. This article walks through three positively exposed stocks from the Short-Term US Treasury and Government Bond...

Aeluma stock: recent moves in context Aeluma (ALMU) shares have seen mixed recent performance, with the stock down 6.4% on the day and 7.5% over the past week, while still up over the past 3 months and year to date. For investors tracking shorter term swings alongside longer term performance, these moves raise questions about how current pricing lines up with Aeluma’s revenue of US$5.196 million and its reported net loss of US$6.004 million. See our latest analysis for Aeluma. At a share...

On 23 June 2026, TD Cowen analyst Kyle Boucher reiterated a positive view on Bio-Techne, describing it as a premier small to mid-cap option despite ongoing life sciences market softness and recent insider selling. His comments, alongside a broader consensus that still sees moderate upside for the company despite funding and demand headwinds, suggest investors are reassessing how Bio-Techne is valued within a challenged sector. Next, we'll examine how this renewed analyst confidence, despite...

MoonLake Immunotherapeutics (MLTX) has become a focus for many investors after strong one-year Phase 3 VELA data for sonelokimab in hidradenitis suppurativa and a planned Biologics License Application filing by the end of September. See our latest analysis for MoonLake Immunotherapeutics. That clinical update has come alongside a sharp move in MoonLake Immunotherapeutics’ share price, with a 7-day share price return of 11.80% and a 30-day share price return of 16.66%. However, the 1-year...

Cencora (NYSE:COR) has launched a multi site pilot of its enhanced Nucleus inventory management solution for specialty physician practices. The company also announced an executive transition in the Chief Human Resources Officer role, bringing in a CHRO from another large corporation. Cencora is drawing attention with these linked operational and leadership moves, as investors weigh what they might mean for the business. The stock recently closed at $281.1, with a value score of 6 and long...

American Tower (NYSE:AMT) is expanding its data center operations as demand tied to AI workloads and multicloud deployments increases. The company is emphasizing its role in digital infrastructure that supports cloud computing alongside its traditional tower leasing business. This shift highlights how AI and cloud trends are influencing American Tower's mix of assets and services. For investors used to thinking of American Tower mainly as a tower landlord, the growing focus on data centers...

Quantum Computing Inc. (NasdaqCM:QUBT) has completed its acquisition of NHanced Semiconductors. The deal brings NHanced in as a wholly owned subsidiary of Quantum Computing Inc. The company has launched Fab 2 to support commercial quantum and photonic hardware production. For Quantum Computing Inc., this acquisition is a significant move into chip manufacturing and advanced packaging, which sit at the heart of quantum and photonic hardware. As more computing workloads push into areas like...

Definium Therapeutics (NasdaqGS:DFTX) reported positive topline Phase 3 results for DT120 in major depressive disorder. The company completed a US$700 million follow on equity offering to fund regulatory and commercialization plans for DT120. The latest data readout and capital raise were announced together as Definium Therapeutics positions DT120 for potential market entry. Definium Therapeutics focuses on treatments for psychiatric conditions, with DT120 targeting major depressive...

Over the last 7 days, the United States market has experienced a 2.3% decline, yet it remains up by 21% over the past year with earnings projected to grow by 19% annually in the coming years. In this context, identifying high growth tech stocks involves looking for companies with strong innovation and scalability potential that can thrive despite short-term market fluctuations.

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 21% over the past year, with earnings forecasted to grow by 19% annually. In this context, identifying stocks that may be trading below their fair value can present opportunities for investors seeking to capitalize on potential growth and resilience in a fluctuating market environment.

From what we can see, insiders were net buyers in System1, Inc.'s ( NYSE:SST ) during the past 12 months. That is...

Over the last 7 days, the United States market has experienced a 2.3% decline, yet it remains up by 21% over the past year with earnings forecasted to grow by 19% annually. In this context of fluctuating market conditions, companies with high insider ownership can often signal strong confidence in future growth prospects, making them appealing considerations for investors seeking robust opportunities.

Over the last 7 days, the U.S. market has dropped 2.3%, but it is up 21% over the past year with earnings forecasted to grow by 19% annually. In light of these conditions, identifying stocks with strong fundamentals and growth potential can be key to navigating market fluctuations. Penny stocks, though an older term, still represent a viable investment area; they often involve smaller or newer companies that offer unique growth opportunities at lower price points.

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it remains robust with a 21% increase over the past year and an earnings forecast predicting a 19% annual growth. In this dynamic environment, identifying lesser-known stocks with strong fundamentals and growth potential can offer unique opportunities for investors seeking to capitalize on these positive trends.

Over the last 7 days, the United States market has dropped 2.3%, though it remains up by 21% over the past year, with earnings forecasted to grow by 19% annually. In this dynamic environment, identifying strong dividend stocks can be an effective strategy for investors seeking stability and income amidst fluctuating market conditions.

BTCS Inc.'s (NASDAQ:BTCS) value has fallen 10% in the last week, but insiders who sold US$1.3m worth of stock over the...

Electricity demand is climbing as data centers, AI workloads, and electrification plans put extra pressure on already stretched grids. At the same time, supply risks in key energy chokepoints are pushing governments and utilities to focus more on resilient, flexible power systems. That mix of higher demand and energy security concerns is pulling attention toward companies exposed to grid equipment, transmission, metering, substation technology, and energy storage. This article walks through 3...

In June 2026, Getty Images announced a multi-year display agreement with OpenAI that will integrate its licensed visual content libraries into ChatGPT’s search and discovery features, enriching on-platform visual responses with authenticated imagery. This move places Getty Images’ rights-cleared library at the heart of one of the world’s most widely used AI interfaces, highlighting how licensed content can underpin more trustworthy visual AI experiences. We’ll now examine how this OpenAI...

Flutter Entertainment plans to delist from the London Stock Exchange and move to a sole NYSE listing under ticker NYSE:FLUT. The company outlined the intention following a review of trading activity and regulatory considerations. The decision marks a structural shift in how Flutter Entertainment engages with public markets and its shareholder base. Flutter Entertainment is set to concentrate its listing in the US market, with NYSE:FLUT becoming its primary trading venue. The move comes at a...